ZBRA vs UI vs VIAV
161 measures in 16 categories, one definition each, computed from filings and market data.
ZBRA62.6
Zebra Technologies Corporation
Technology · Communication Equipment
$369.01 −2.25%$17.5B mkt cap
Score DNA
VIAV30.9
Viavi Solutions Inc.
Technology · Communication Equipment
$33.38 −9.34%$8.2B mkt cap
Score DNA
Price, rebased to 100 three years ago
ZBRA UI VIAV · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | ZBRA | UI | VIAV |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 1 | 0 | 0 |
| Last Congress purchase | 2026-05-01 | — | — |
| 13F net change in holders | +11 | −26 | +100 |
| ETFs adding shares, 30d | 476 | 177 | 365 |
| ETFs trimming, 30d | 510 | 109 | 179 |
| Net ETF funds, 30d | −34 | +68 | +186 |
Valuation
16 measures| Measure | ZBRA | UI | VIAV |
|---|---|---|---|
| P/E (TTM) | 32.4x
33rd
|
37.9x
50th
|
— |
| PEG (P/E ÷ 3-yr EPS CAGR) | — | 1.15
17th
|
— |
| Price / sales | 3.0x
48th
|
11.1x
90th
|
5.4x
62nd
|
| Price / book | 5.1x
57th
|
25.3x
90th
|
5.7x
62nd
|
| Price / tangible book | — | 22.5x
86th
|
29.5x
100th
|
| Price / free cash flow | 19.3x
19th
|
40.0x
69th
|
99.1x
88th
|
| Price / operating cash flow | 17.8x
22nd
|
39.2x
67th
|
72.1x
83rd
|
| Enterprise value | $20.3B
76th
|
$35.8B
81st
|
$8.3B
67th
|
| EV / sales | 3.5x
52nd
|
10.9x
90th
|
5.4x
62nd
|
| EV / EBITDA | 17.6x
33rd
|
29.8x
72nd
|
48.0x
94th
|
| EV / EBIT | 21.6x
17th
|
30.3x
50th
|
129.6x
94th
|
| EV / free cash flow | 22.4x
38th
|
39.4x
69th
|
99.7x
88th
|
| Earnings yield | 3.1%
81st
|
2.6%
71st
|
-0.4%
33rd
|
| FCF yield | 5.2%
86th
|
2.5%
48th
|
1.0%
33rd
|
| Operating cash flow yield | 5.6%
81st
|
2.6%
43rd
|
1.4%
29th
|
| Graham number (per share) | $127.42
100th
|
$92.10
92nd
|
— |
Profitability (TTM)
12 measures| Measure | ZBRA | UI | VIAV |
|---|---|---|---|
| Gross margin | 48.9%
67th
|
46.2%
62nd
|
57.7%
86th
|
| EBITDA margin | 19.7%
71st
|
36.7%
90th
|
11.3%
48th
|
| Operating margin | 16.1%
81st
|
36.2%
100th
|
6.9%
57th
|
| EBIT margin | 16.0%
81st
|
36.1%
100th
|
4.2%
24th
|
| Net margin | 9.2%
71st
|
29.3%
95th
|
-2.0%
33rd
|
| NOPAT margin | 12.2%
71st
|
29.4%
95th
|
-12.3%
5th
|
| FCF margin | 15.5%
71st
|
27.8%
100th
|
5.5%
33rd
|
| Operating cash flow margin | 16.7%
67th
|
28.4%
95th
|
7.5%
24th
|
| R&D / revenue | 10.6%
33rd
|
6.2%
14th
|
17.3%
71st
|
| SG&A / revenue | 20.0%
29th
|
3.7%
0th
|
30.9%
71st
|
| Stock comp / revenue | 3.0%
45th
|
0.2%
0th
|
3.6%
50th
|
| Effective tax rate | 24.0%
83rd
|
18.8%
44th
|
— |
Returns on capital
11 measures| Measure | ZBRA | UI | VIAV |
|---|---|---|---|
| ROE (on average equity) | 15.3%
62nd
|
91.1%
95th
|
-2.7%
33rd
|
| ROA | 6.5%
67th
|
52.4%
100th
|
-1.3%
33rd
|
| ROIC | 11.5%
57th
|
105.9%
95th
|
-12.5%
5th
|
| ROCE | 20.2%
90th
|
75.3%
100th
|
3.1%
33rd
|
| Return on tangible assets | 11.3%
86th
|
64.6%
100th
|
2.7%
29th
|
| Cash ROIC (OCF / invested capital) | 15.7%
38th
|
102.2%
86th
|
7.6%
24th
|
| Gross profitability (GP / assets) | 33.1%
57th
|
68.8%
95th
|
32.4%
52nd
|
| ROIC, 3-yr average | 7.6%
47th
|
675.5%
100th
|
-4.7%
13th
|
| ROIC, 5-yr average | 11.4%
50th
|
— | -1.3%
22nd
|
| ROE, 5-yr average | 15.9%
89th
|
— | 0.9%
44th
|
| Incremental ROIC | 71.1%
80th
|
69.3%
75th
|
-18.5%
25th
|
Growth
17 measures| Measure | ZBRA | UI | VIAV |
|---|---|---|---|
| Revenue growth (TTM YoY) | 12.7%
45th
|
27.2%
65th
|
40.0%
85th
|
| Revenue growth (QoQ) | 4.1%
19th
|
18.9%
76th
|
8.9%
57th
|
| Revenue CAGR, 3 yr | 2.1%
25th
|
19.0%
80th
|
11.1%
60th
|
| Revenue CAGR, 5 yr | 2.5%
15th
|
11.5%
65th
|
4.8%
20th
|
| Gross profit CAGR, 3 yr | 3.7%
25th
|
25.7%
85th
|
11.6%
55th
|
| Operating income CAGR, 3 yr | 2.2%
46th
|
29.6%
85th
|
2.1%
38th
|
| Net income growth (TTM YoY) | -1.6%
12th
|
34.9%
75th
|
— |
| Net income CAGR, 3 yr | -6.1%
11th
|
33.1%
78th
|
— |
| EPS growth (TTM YoY) | 0.6%
25th
|
34.8%
88th
|
— |
| EPS CAGR, 3 yr | -5.4%
11th
|
33.0%
78th
|
— |
| EPS CAGR, 5 yr | -5.5%
22nd
|
10.0%
56th
|
— |
| FCF growth (TTM YoY) | 6.0%
50th
|
44.9%
93rd
|
33.5%
86th
|
| FCF CAGR, 3 yr | 83.6%
82nd
|
— | 9.5%
36th
|
| Operating cash flow CAGR, 3 yr | 63.5%
86th
|
— | -0.1%
29th
|
| Book value CAGR, 3 yr | 5.4%
47th
|
— | 26.6%
74th
|
| Dividend CAGR, 3 yr | — | 10.0% | — |
| Sustainable growth rate | 15.3%
42nd
|
72.7%
100th
|
— |
Margin history & stability
7 measures| Measure | ZBRA | UI | VIAV |
|---|---|---|---|
| Gross margin, 3-yr average | 48.0%
65th
|
42.6%
60th
|
57.2%
85th
|
| Operating margin, 3-yr average | 13.4%
85th
|
31.5%
100th
|
5.3%
50th
|
| Net margin, 3-yr average | 8.4%
75th
|
25.0%
100th
|
-0.5%
40th
|
| FCF margin, 3-yr average | 14.0%
80th
|
26.5%
100th
|
7.0%
40th
|
| Revenue stability (0-1) | 0.07
5th
|
0.68
55th
|
0.15
15th
|
| Earnings stability (0-1) | 0.17
40th
|
0.35
55th
|
0.48
80th
|
| Margin stability (0-1) | 0.98
90th
|
0.90
45th
|
0.99
100th
|
Liquidity (latest quarter)
7 measures| Measure | ZBRA | UI | VIAV |
|---|---|---|---|
| Cash & short-term investments | $157.0M
29th
|
$611.2M
67th
|
$649.8M
71st
|
| Net cash (− = net debt) | −$2.8B
14th
|
$531.2M
86th
|
−$49.0M
33rd
|
| Working capital | −$1.9B
5th
|
$1.2B
81st
|
$576.0M
62nd
|
| Current ratio | 0.52
0th
|
2.93
76th
|
1.85
43rd
|
| Quick ratio | 0.33
0th
|
1.68
57th
|
1.62
48th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.04
0th
|
0.98
62nd
|
0.95
57th
|
| Defensive interval (days) | 229 days
14th
|
1,022 days
81st
|
474 days
43rd
|
Leverage & solvency (latest quarter)
13 measures| Measure | ZBRA | UI | VIAV |
|---|---|---|---|
| Total debt | $3.0B
86th
|
$80.0M
38th
|
$698.8M
71st
|
| Debt / equity | 0.86
76th
|
0.06
29th
|
0.48
67th
|
| Net debt / equity | 0.82
86th
|
−0.37
29th
|
0.03
67th
|
| Debt / assets | 34.3%
86th
|
3.6%
29th
|
25.8%
81st
|
| Debt / capital | 46.3%
76th
|
5.3%
29th
|
32.5%
67th
|
| Debt / EBITDA | 2.57
72nd
|
0.07
0th
|
4.06
100th
|
| Net debt / EBITDA | 2.44
94th
|
−0.44
50th
|
0.28
61st
|
| Interest coverage (EBIT / interest) | 4.1x
33rd
|
— | 1.3x
20th
|
| Cash interest coverage | 4.3x
38th
|
— | 2.4x
19th
|
| Debt payback (years of OCF) | 3.0 yrs
72nd
|
0.1 yrs
6th
|
6.1 yrs
94th
|
| Liabilities / assets | 60.2%
71st
|
34.5%
33rd
|
46.5%
52nd
|
| IS credit model rating | BBB+ | AA+ | B |
| Implied credit spread (bps) | 225
62nd
|
65
0th
|
750
100th
|
Efficiency
11 measures| Measure | ZBRA | UI | VIAV |
|---|---|---|---|
| Asset turnover | 0.71
57th
|
1.79
100th
|
0.65
43rd
|
| Fixed asset turnover | 11.38
52nd
|
21.57
81st
|
6.76
29th
|
| Inventory turnover | 4.2
57th
|
2.4
19th
|
4.7
71st
|
| Receivables turnover | 7.2
57th
|
12.0
100th
|
5.0
24th
|
| Days sales outstanding | 51 days
43rd
|
30 days
0th
|
74 days
76th
|
| Days inventory outstanding | 87 days
43rd
|
151 days
81st
|
78 days
29th
|
| Days payables outstanding | 80 days
81st
|
62 days
57th
|
46 days
24th
|
| Cash conversion cycle (days) | 58 days
14th
|
119 days
67th
|
105 days
57th
|
| Capex / revenue | 1.3%
19th
|
0.6%
5th
|
2.0%
38th
|
| Capex / depreciation | 0.35
29th
|
1.04
62nd
|
0.29
19th
|
| Operating expense ratio | 32.4%
43rd
|
9.5%
0th
|
60.0%
95th
|
Cash flow & earnings quality
7 measures| Measure | ZBRA | UI | VIAV |
|---|---|---|---|
| Operating cash flow / net income | 1.82
58th
|
0.97
17th
|
— |
| FCF / net income | 1.68
75th
|
0.95
25th
|
— |
| FCF / operating cash flow | 92.3%
83rd
|
97.9%
100th
|
72.7%
39th
|
| Capex / operating cash flow | 7.7%
17th
|
2.1%
0th
|
27.3%
61st
|
| Accruals ratio | -5.3%
62nd
|
1.7%
86th
|
-6.1%
48th
|
| Sloan accruals ratio | -34.9%
0th
|
39.7%
90th
|
7.3%
62nd
|
| Earnings quality score (0-1) | 0.75
17th
|
0.75
17th
|
— |
Scores & forensic checks
15 measures| Measure | ZBRA | UI | VIAV |
|---|---|---|---|
| IS score | 63
67th
|
85
100th
|
31
14th
|
| IS profitability | 59
81st
|
94
100th
|
26
24th
|
| IS growth | 48
20th
|
86
95th
|
52
25th
|
| IS value | 42
76th
|
49
86th
|
23
10th
|
| IS momentum | 77
50th
|
91
80th
|
50
20th
|
| IS risk (safety) | 80
43rd
|
100
57th
|
0
0th
|
| IS quality | 75
67th
|
88
100th
|
54
43rd
|
| IS balance sheet | 41
14th
|
97
100th
|
71
48th
|
| IS earnings quality | 71
76th
|
79
100th
|
47
38th
|
| IS cash flow | 66
67th
|
87
95th
|
49
38th
|
| Piotroski F-score (0-9) | 6
38th
|
7
71st
|
6
38th
|
| Altman Z-score | 3.2
43rd
|
30.4
100th
|
−29.9
0th
|
| Beneish M-score | −2.27
75th
|
−2.19
80th
|
−2.43
60th
|
| Ohlson O-score | −7.02
81st
|
−12.11
0th
|
−7.24
67th
|
| IS credit score | 61
33rd
|
93
81st
|
29
0th
|
Size (TTM)
8 measures| Measure | ZBRA | UI | VIAV |
|---|---|---|---|
| Market cap | $17.5B
76th
|
$36.4B
81st
|
$8.2B
71st
|
| Revenue | $5.8B
86th
|
$3.3B
76th
|
$1.5B
62nd
|
| EBITDA | $1.2B
81st
|
$1.2B
86th
|
$172.0M
67th
|
| Net income | $539.0M
81st
|
$960.3M
90th
|
−$30.4M
24th
|
| Free cash flow | $904.0M
81st
|
$908.9M
86th
|
$82.8M
52nd
|
| Total assets | $8.6B
86th
|
$2.2B
48th
|
$2.7B
57th
|
| Shareholders' equity | $3.4B
86th
|
$1.4B
52nd
|
$1.4B
57th
|
| Employees | 10,700
86th
|
1,818
38th
|
4,100
57th
|
Price performance
9 measures| Measure | ZBRA | UI | VIAV |
|---|---|---|---|
| 1 day | −2.2% | −2.7% | −9.3% |
| 1 week | −4.7% | −8.5% | −26.6% |
| 1 month | +6.1% | +0.8% | −3.9% |
| 3 months | +39.4% | +13.0% | −15.3% |
| 6 months | +57.4% | −44.5% | −24.4% |
| Year to date | +48.6% | +6.3% | +83.9% |
| 1 year | +25.8% | −19.7% | +156.6% |
| 3 years, cumulative | +69.9% | +416.4% | +303.6% |
| 5 years, cumulative | −26.0% | +104.1% | +118.5% |
Technicals
4 measures| Measure | ZBRA | UI | VIAV |
|---|---|---|---|
| RSI 14 | 48.8 | 50.4 | 34.3 |
| From 52-week high | −5.6% | −45.3% | −44.8% |
| From 52-week low | +85.4% | +20.2% | +161.4% |
| Beta | 1.58 | 1.31 | 1.21 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17